Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Therapy for Patients With Metastatic Adenocarcinoma of the Pancreas Determined by Genetic Testing and Avatar Model Generation

NCT02795650 is registered in ClinicalTrials.gov with Hospital Universitario de Fuenlabrada as lead sponsor.

NCT NCT02795650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02795650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Therapy for Patients With Metastatic Adenocarcinoma of the Pancreas Determined by Genetic Testing and Avatar Model Generation
Lead sponsor
Hospital Universitario de Fuenlabrada
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2016
Completion date
September 30, 2022
Enrollment
146 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma